Home / Peptide legality / North Carolina
Are peptides legal in North Carolina?
Peptides fall into a gray legal zone in North Carolina: FDA-approved peptide medicines are legal when dispensed under a valid prescription, but unapproved research peptides such as BPC-157 and TB-500 remain outside the lawful medical supply chain.
Legal status overview
Peptides fall into a gray legal zone in North Carolina, with legality determined by the specific peptide and how it is supplied. FDA-approved peptide drugs, including brand GLP-1 medicines like Wegovy® (semaglutide) and Zepbound® (tirzepatide), are legal to prescribe and dispense through North Carolina licensed pharmacies. North Carolina Administrative Code Chapter 46 governs pharmacy compounding and requires a valid prescription, and the state has no standalone peptide ban, so legality tracks the federal 503A and 503B framework. Research peptides such as BPC-157 and TB-500 are not FDA-approved, are no longer clearly eligible for compounding, and are usually sold only as research chemicals, which places them outside lawful clinical use.
Key points
- North Carolina has no statute that specifically bans peptides; legality follows the federal 503A and 503B compounding framework plus North Carolina Board of Pharmacy rules. [1]
- North Carolina Administrative Code 21 NCAC 46 .2801 governs pharmacy compounding and permits dispensing a compounded preparation only pursuant to a valid prescription. [6]
- The North Carolina Board of Pharmacy sets compounding record and master formula standards that a pharmacy must meet when preparing peptides for a patient. [7]
- A peptide is eligible for 503A compounding only if it is on the FDA 503A Bulks List (Category 1), has a USP or NF monograph, or is a component of an FDA-approved drug. [1]
- Compounded GLP-1 medicines are no longer routinely available after the FDA declared the tirzepatide and semaglutide shortages resolved in 2025 and set deadlines to stop mass compounding. [2]
- BPC-157 and TB-500 were removed from FDA Category 2 in 2026 but not added to the Category 1 Bulks List, so they remain in regulatory limbo rather than cleared for compounding. [4]
- The FDA Pharmacy Compounding Advisory Committee reviewed BPC-157 and TB-500 in July 2026, confirming the status of these peptides is still unsettled. [3]
- Growth hormone (somatropin) is legal only by prescription for FDA-recognized conditions; federal law makes distribution for anti-aging or athletic use a crime even with a prescription. [5]
Compound-by-compound status
| BPC-157 Gray area | Not FDA-approved; not a generic; not evaluated by the FDA. Removed from FDA Category 2 in 2026 but not placed on the Category 1 Bulks List, so it is not clearly eligible for routine 503A compounding in North Carolina and is mostly sold as a research chemical. |
|---|---|
| GLP-1 class (semaglutide, tirzepatide) Restricted | FDA-approved brand products such as Wegovy® (semaglutide), Ozempic® (semaglutide), Zepbound® (tirzepatide), and Mounjaro® (tirzepatide) are legal by prescription. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA, and are limited to narrow documented-need cases now that the shortages are resolved. |
| TB-500 (thymosin beta-4 fragment) Gray area | Not FDA-approved; not a generic; not evaluated by the FDA. Under FDA advisory-committee review for the 503A Bulks List and typically sold only as a research chemical, so lawful clinical access in North Carolina is limited. |
| Growth hormone / somatropin Restricted | A prescription drug legal only for FDA-recognized medical conditions. Federal law (21 USC 333(e)) makes distribution for anti-aging, bodybuilding, or athletic enhancement a crime even with a prescription. |
Frequently asked questions
Are peptides legal in North Carolina?
It depends on the peptide. FDA-approved peptide medicines are legal with a valid prescription from a North Carolina licensed provider. Unapproved research peptides like BPC-157 and TB-500 are not clearly available through lawful compounding, so they occupy a gray zone. This is general information, not legal or medical advice.
Can I still get compounded GLP-1 medicines in North Carolina?
Only in limited cases. After the FDA resolved the semaglutide and tirzepatide shortages in 2025, routine compounding wound down. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA. Most patients are moved to FDA-approved brands such as Wegovy® (semaglutide) or Zepbound® (tirzepatide).
Do I need a prescription for peptides in North Carolina?
Yes. North Carolina rules allow a pharmacy to dispense a compounded preparation only pursuant to a valid prescription from a licensed provider. Products labeled as research chemicals are not authorized for human use.
Is BPC-157 legal in North Carolina?
BPC-157 is not FDA-approved and remains in federal compounding limbo after being removed from Category 2 without being added to the approved Bulks List. North Carolina has no separate ban, but the federal status limits lawful medical access.
Who regulates peptide compounding in North Carolina?
The North Carolina Board of Pharmacy oversees pharmacy licensing and compounding standards under 21 NCAC 46, working alongside the federal FDA framework that determines which peptides may be compounded.
Sources
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act (FDA) (retrieved 2026-09-21)
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize (FDA) (retrieved 2026-09-21)
- July 23-24, 2026 Meeting of the Pharmacy Compounding Advisory Committee (FDA) (retrieved 2026-09-21)
- BPC-157 in 2026: Why Regulatory Limbo Is Not the Same as a Green Light (Holt Law) (retrieved 2026-09-21)
- 21 U.S. Code 333(e) definition of human growth hormone (Cornell Legal Information Institute) (retrieved 2026-09-21)
- 21 NCAC 46 .2801 Compounding (North Carolina Administrative Code) (retrieved 2026-09-21)
- Compounding Record and Master Formula Guidance Document (North Carolina Board of Pharmacy) (retrieved 2026-09-21)
Last researched: 2026-09-21.